Hemagen Diagnostics, Inc. (HMGN)
OTCMKTS · Delayed Price · Currency is USD
0.0016
+0.0014 (700.00%)
At close: Apr 7, 2026
Hemagen Diagnostics Market Cap
Hemagen Diagnostics has a market cap or net worth of $24.8 thousand as of April 16, 2026. Its market cap has decreased by -80.00% in one year.
Market Cap
24.80K
Enterprise Value
n/a
Revenue
4.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 23, 1996, Hemagen Diagnostics's market cap has decreased from 20.30M to 24.80K, a decrease of -99.88%. That is a compound annual growth rate of -20.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 24.80K | 700.00% |
| Dec 9, 2025 | 3.10K | 100.00% |
| Dec 28, 2022 | 1.55K | -98.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nascent Biotech | 51.85K |
| Ocean Biomedical | 46.47K |
| Itoco | 42.82K |
| IMV Inc. | 29.42K |
| Statera Biopharma | 29.03K |
| America Great Health | 21.15K |
| Health Sciences Group | 20.51K |
| Trevena | 19.18K |